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Background: To investigate epigenetic patterns associated with aneuploidy we used constitutional trisomy 8
mosaicism (CT8M) as a model, enabling analyses of single cell clones, harboring either trisomy or disomy 8, from
the same patient; this circumvents any bias introduced by using cells from unrelated, healthy individuals as
controls. We profiled gene and miRNA expression as well as genome-wide and promoter specific DNA methylation
and hydroxymethylation patterns in trisomic and disomic fibroblasts, using microarrays and methylated DNA
immunoprecipitation.
Results: Trisomy 8-positive fibroblasts displayed a characteristic expression and methylation phenotype distinct
from disomic fibroblasts, with the majority (65%) of chromosome 8 genes in the trisomic cells being overexpressed.
However, 69% of all deregulated genes and non-coding RNAs were not located on this chromosome. Pathway
analysis of the deregulated genes revealed that cancer, genetic disorder, and hematopoiesis were top ranked. The
trisomy 8-positive cells displayed depletion of 5-hydroxymethylcytosine and global hypomethylation of gene-poor
regions on chromosome 8, thus partly mimicking the inactivated X chromosome in females.
Conclusions: Trisomy 8 affects genes situated also on other chromosomes which, in cooperation with the
observed chromosome 8 gene dosage effect, has an impact on the clinical features of CT8M, as demonstrated by
the pathway analysis revealing key features that might explain the increased incidence of hematologic
malignancies in CT8M patients. Furthermore, we hypothesize that the general depletion of hydroxymethylation and
global hypomethylation of chromosome 8 may be unrelated to gene expression regulation, instead being
associated with a general mechanism of chromatin processing and compartmentalization of additional
chromosomes.
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Constitutional trisomy 8 mosaicism (CT8M) is a rela-
tively rare chromosomal disorder with an estimated
frequency of approximately 1/25,000 to 1/50,000 [1].
However, since the phenotypes of individuals with
CT8M vary quite extensively, ranging from severe
malformations with impaired cognitive functioning to
rather discrete dysmorphic changes [2], the true preva-
lence may well be higher. Characteristic clinical features
of CT8M include elongated facial features, abnormally
shaped ears, strabismus, camptodactyly, clinodactyly,
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distribution, and reproduction in any mediumanomalies, cardiovascular and urogenital malformations
and mild to moderate mental retardation [3]. As regards
acquired trisomy 8, it is one of the most common abnor-
malities in malignant myeloid disorders, such as acute
myeloid leukemia, myelodysplastic syndromes and mye-
loproliferative neoplasms [4,5]. Interestingly, based on
several case reports on myeloid malignancies in patients
with CT8M [see Additional file 1: Table S1], CT8M
seems to be associated with an increased risk of these
disorders. It has even been suggested, albeit in a small
patient series, that the ‘acquired’ +8 in myeloid diseases
in some instances could represent an unrecognized
CT8M [6]. This, however, remains to be confirmed or
refuted in larger studies.
There is ample evidence that CT8M arises post-
zygotically through a mitotic error, with no preferentialtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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[7-11]. The pathogenetically important consequence of
CT8M is most likely, as for numerical abnormalities in
general, a dosage effect, with overexpression of genes on
the gained chromosome [12]. However, it is unknown
whether all chr8 genes are upregulated in CT8M. In a
previous study [10], a single gene (GSR at 8p) was inves-
tigated in two patients and shown to have an increased
activity. To date, no global gene expression analyses of
CT8M cases have been reported, but considering
that myeloid malignancies with acquired trisomy 8
overexpress most, but not all, genes on this chromosome
[13-15], it is plausible that the same holds true also for
CT8M. Furthermore, it is also unclear whether CT8M is
associated with epigenetic changes involving chr8, akin
to the methylation changes on chr21 in Down syndrome
(DS) [16,17]. We have previously shown that most tri-
and tetrasomic chromosomes in high hyperdiploid (51
to 67 chromosomes) acute lymphoblastic leukemia
(ALL), one of the most common subtypes of childhood
ALL [18], are globally less methylated than their disomic
counterparts and suggested that this could be a general
phenomenon associated with gains of chromosomes, ir-
respective of whether they are constitutional or acquired
[19]. However, this has, until the present study, not been
investigated.
In order to further our understanding of gene expres-
sion patterns and epigenetic mechanisms associated with
gain of chr8, we used CT8M as a model, allowing ana-
lyses of single cell-derived fibroblast clones, harboring
either trisomy or disomy 8, from the same patient. This
model enables comparisons between identical cell types
(for example, fibroblasts), differing only in respect to
chr8 content, from a single individual and, hence,
circumvents the bias introduced when comparing the
epigenetic findings with unrelated, healthy individuals.
We used this model to profile global gene and
microRNA (miRNA) expression as well as genome-wide
and gene promoter specific DNA methylation and
hydroxymethylation patterns in trisomic and disomic
fibroblasts from a patient with CT8M, using microarrays
and methylated DNA immunoprecipitation (MeDIP).
Results
Unsupervised HCA of gene and miRNA expression
A standard unsupervised hierarchical cluster analysis
(HCA), after using a variance filter with a cut-off value
of 50% of the highest standard deviating genes to limit
the number of probes and a Pearson correlation test [20]
for average linkage clustering, was used to investigate
similarities and differences in global gene and miRNA
expression patterns among disomy 8, trisomy 8, and ref-
erences. Unsupervised HCA of only gene expression and
of both gene and miRNA expression data clustered thetrisomy 8 cultures together but did not differentiate be-
tween disomy 8 and reference cultures [see Additional file
2: Figure S1], whereas unsupervised HCA of only miRNA
expression data was less accurate in clustering the
various culture groups [see Additional file 2: Figure S1].
To test for a possible bias introduced by in vitro cultur-
ing, we performed long-term culturing (16 weeks) of
disomy 8 and trisomy 8 cells and repeated the analysis.
Unsupervised HCA clustered the long-term cultures to-
gether with their short-term counterparts, indicating a
minimal impact of in vitro effects on gene and miRNA
expression [see Additional file 2: Figure S1]. It should
be stressed that we cannot exclude the possibility of an
effect of culturing as such during the first eight weeks
compared with uncultured cells. However, since ana-
lyses could not be performed without expansion of
single cell clones, this could not be addressed in the
present study.PCA and supervised HCA of gene and miRNA expression
Principal component analysis (PCA) identified 1,650
unique probes (5% of all 33,297 probes analyzed in our
expression dataset) that displayed significant expression
differences among the trisomy 8, disomy 8, and refer-
ence groups. Supervised HCA of these probes correctly
clustered the three groups, with the trisomy 8 cultures
being placed in the same branch as the disomy 8 cul-
tures (Figure 1A). When performing PCA only of chr8
probes (n = 1,087), 87 significant genes (12% of the 728
known HG19 protein-coding genes on this chromo-
some) were identified. Supervised HCA of these genes
again accurately clustered the three groups, this time
with the trisomy 8 cultures being placed in a single
branch (Figure 1B).
To illustrate the expression levels of genes on chr8,
the average median-centered gene expression in the tri-
somy 8, disomy 8, and reference cultures was plotted
against the location of each gene on this chromosome,
revealing a global overexpression of chr8 genes in the
trisomy 8 cultures compared with both the disomy 8
and reference cultures (Figure 1C and Additional file 3:
Figure S2); in contrast, the expression levels in the di-
somy 8 and the reference cultures were very similar
(Figure 1C). In total, among the 728 protein-coding
genes on chr8, 476 (65%) were overexpressed in the tri-
somy 8 cells compared with the disomy 8 cells, as
ascertained by measuring the median expression values
in the two culture groups.
PCA and supervised HCA of global miRNA expres-
sion, based on 108 significant probes, also correctly
clustered the three groups, placing the trisomy 8 cul-
tures in the same branch as the disomy 8 cultures
(Figure 1D). Analysis of only chr8 miRNA expression
Figure 1 (See legend on next page.)
Davidsson et al. Epigenetics & Chromatin 2013, 6:18 Page 3 of 13
http://www.epigeneticsandchromatin.com/content/6/1/18
(See figure on previous page.)
Figure 1 PCA and supervised HCA of gene and miRNA expression accurately cluster the trisomy 8, disomy 8, and reference cultures.
(A) The PCA identified 1,650 probes that displayed significant expression differences among the trisomy 8, disomy 8, and reference groups (left).
Supervised HCA of these probes accurately clustered the subgroups, as illustrated in the heat map to the right. (B) A similar pattern was
observed when analyzing only chr8 data, with the PCA identifying 87 genes (left) and HCA accurately clustering the subgroups (right), placing
the trisomy 8 cultures in a single branch. (C) Median-centered gene expression of chr8 demonstrated that the majority of the genes on this
chromosome in the trisomy 8 cultures were upregulated compared with the disomy 8 cultures (left), whereas few differences were observed
when comparing the disomy 8 cultures with the reference cultures (right). (D) The PCA identified 108 miRNA probes that displayed significant
expression differences between the trisomy 8, disomy 8, and reference groups (left). Supervised HCA of these probes grouped the cultures
correctly (right). chr8, chromosome 8; HCA, hierarchical cluster analysis; miRNA, microRNA; PCA, principal component analysis.
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expressed probes (data not shown).
Genes and miRNAs possibly contributing to the CT8M
phenotype and their clinical and biological functions
A multiple testing approach identified 25 protein-coding
genes, one small nucleolar RNA, and one miRNA that
were significantly overexpressed and four genes and one
miRNA that were significantly underexpressed in the
trisomy 8 cultures as compared with both the disomy
8 and reference cultures. The over- or underexpression
of seven of the genes identified was validated by
real-time quantitative PCR (qPCR) [see Additional file 4:
Figure S3]. As seen in Table 1, 10 (31%) of these 32
genes/miRNAs are located on chr8. In addition, a t-test of
the global gene expression patterns in the trisomy 8 versus
the disomy 8 cultures revealed 502 differentially expressed
genes. The top clinical conditions and biological features
associated with these genes, as identified using an Ingenu-
ity pathway analysis (Ingenuity Systems, Redwood City,
CA, USA), are provided in Additional file 5: Table S2.
Hypermethylated and hyperhydroxymethylated
promoters/CpG islands in relation to gene expression
An edge-preserving smoother analysis identified 150 to
200 genes that were highly enriched for 5-methylcytosine
(5 mC) and/or 5-hydroxymethylcytosine (5 hmC) in the
disomy 8, trisomy 8, and reference groups, respectively. As
seen in Additional file 6: Table S3, approximately 80% of
the hypermethylated genes were underexpressed, whereas
only a minority of the hyperhydroxymethylated genes
was under- or overexpressed, as ascertained by a t-test.
When analyzing only genes on chr8, a similar pattern
emerged – 17 (89%) of 19 hypermethylated genes
were underexpressed, whereas only 8 (32%) of 25
hyperhydroxymethylated genes were underexpressed.
The patterns of hypermethylated and
hyperhydroxymethylated promoters/CpG islands
The levels of promoter-specific methylation on the auto-
somes in the trisomy 8 group did not differ significantly
from the corresponding levels in the disomy 8 and refer-
ence groups combined [see Additional file 7: Figure S4],
nor did the levels of 5 hmC, with the notable exceptionof chr8 on which the 5 hmC levels were significantly
lower (P <0.05; t-test) in the trisomy 8 group (Figure 2
and Additional file 8: Figure S5). As regards the X
chromosome, its promoters/CpG islands were generally
(irrespective of gender and culture group) significantly
(P <0.05; t-test) less hydroxymethylated than all ‘auto-
somal’ promoters/CpG islands [see Additional file 9:
Figure S6]. The female reference displayed a higher level
of promoter-specific methylation on the X chromosome
(Figure 3A) as well as a lower level of promoter-specific
hydroxymethylation (Figure 3B) compared with the XY
cultures.
Genome-wide methylation patterns
PCA identified 781 unique clones, comprising 2.4% of
the 32,433 bacterial artificial chromosomes (BACs) in
the array, that displayed significant (P <0.05) differences
in methylation between the trisomy 8, disomy 8, and ref-
erence groups. Supervised HCA of these clones clus-
tered the three groups, with the trisomy 8 cultures being
placed in the same branch as the disomy 8 cultures
(Figure 4A). PCA of only BACs on chr8 revealed 81 sig-
nificant clones (6.2% of the 1,312 BACs covering chr8),
and supervised HCA of these BACs again accurately
clustered the three groups, this time with the trisomy 8
cultures constituting a single branch (Figure 4B).
An independent and weighted ANOVA and a Tukey
honestly significant difference (HSD) test identified a
significant (P <0.01) global hypomethylation of gene-
poor regions on chr8 in trisomy 8 cultures but not in
the disomy 8 or reference cultures (Figure 4C and D).
This pattern was not observed on any of the other
autosomes (Figure 4E). However, a similar global
hypomethylation of gene-poor regions was seen on the
X chromosome in the female reference compared with
all XY cultures, irrespective of sample type (Figure 4F).
Discussion
Aneuploidy is a well-studied phenomenon in human
cancer as well as in various model organisms, for ex-
ample Arabidopsis thaliana, Drosophila melanogaster,
Mus musculus, and Saccharomyces cerevisiae, that in
recent years has received increased attention as regards
its effects on cellular physiology, transcriptional
Table 1 Genes and miRNAs significantly associated with the presence of trisomy 8
Gene/RNA symbols Chr positiona Function/process/componenta Fold changeb
DES 2q35 Cytoskeleton 11.8762965
CHSY3 5q23.3 Transferase 2.6232108
EDNRAc 4q31.22 G-protein coupled receptor activity 2.55418755
CRYABc 11q23.1 Small heat shock protein 2.3484328
KCTD20 6p21.31 Ion transport 2.33678525
SCRN1 7p14.3 Exocytosis 2.09512935
POPDC2 3q13.33 Membrane associated protein 2.0460034
LDB3 10q23.2 Cytoskeleton 2.0369906
ZNF185 Xq28 Protein-protein interactions 2.03330695
LRP12c 8q22.3 Lipoprotein receptor related protein 1.936707
AGPAT6c 8p11.21 Transferase 1.72648325
ENTPD4c 8p21.2-21.3 Hydrolase 1.7125851
RAB3GAP2 1q41 Exocytosis 1.6605436
COX6C 8q22.2 Respiratory electron transport chain 1.63403665
TNFRSF10A 8p21.3 Apoptosis 1.6329978
MIR151 8q24.3 Post-transcriptional regulation 1.6319659
FNBP1 9q34.11 Protein binding 1.59805445
TNKS 8p23.1 Transferase 1.5799036
RAB2A 8q12.1 GTPase 1.5733374
SLC4A3 2q35 Ion transport 1.47450405
ELP3 8p21.1 Regulation of transcription 1.4660848
OSTM1 6q21 Osteoclast differentiation 1.4356524
DMPK 19q13.32 Kinase 1.4022396
PFN2 3q25.1 Cytoskeleton 1.3931477
SNORD115-32 15q11.2 Small nucleolar RNA 1.37446365
RPS6KA1 1p36.11 Kinase 1.34011185
INTS10 8p21.3 Small nuclear RNA processing 1.3153658
CASP4d 11q22.3 Apoptosis −1.45109678
ARRDC4 15q26.2-26.3 Signal transduction −1.498037415
KITLG 12q21.32 Signal transduction −1.66295902
CPXM2d 10q26.13 Peptidase −1.785911
MIR424 Xq26.3 Post-transcriptional regulation −3.3616748
aThe chromosome (Chr) positions are based on GRCh37 in Ensembl (http://www.ensembl.org), whereas the functions/processes/components are based on NCBI
Gene (http://www.ncbi.nlm.nih.gov/gene); bcompared to the baseline expression in the dataset; coverexpression confirmed by quantitative real-time PCR
[see Additional file 4: Figure S3].
dunderexpression confirmed by quantitative real-time PCR [see Additional file 4: Figure S3]. miRNAs, microRNAs; NCBI, National Center for Biotechnology Information.
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studies have revealed that aneuploidy is associated with
a general proliferative disadvantage, species-conserved
stress related gene expression patterns regardless of
gained chromosome as well as increased and defect
mitotic recombination and DNA repair, resulting in
genomic instability. In humans, constitutional aneu-
ploidy, for example, loss or gain of sex chromosomes
or trisomy of chromosomes 13, 18, or 21, is a major
cause of miscarriage and developmental disturbances.Prior to the present study, gene expression patterns in
patients with constitutional trisomies have exclusively
been compared with expression signatures derived
from disomic control cells from unrelated healthy indi-
viduals [25-31]. The differences previously observed
might, hence, not only represent the presence of a spe-
cific trisomy but also interindividual variations and
comparisons between non-identical cell types, with the
latter introducing severe interpretation difficulties. For
this reason, we used single cell cloning of fibroblasts
Figure 2 Promoter-specific hydroxymethylation levels on
chromosome 8 are significantly lower in the trisomy 8
compared with the disomy 8/reference cultures. The levels of
average promoter-specific hydroxymethylation on chr8 in the
trisomy 8 and in the disomy 8 and reference cultures combined
were log2-converted, median-centered, and plotted against
genomic positions. Significantly lower levels (P <0.05; t-test) were
observed in the trisomy 8 cultures. chr8, chromosome 8.
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biased manner, the epigenetic changes associated with
gain of chr8. Because several human chromosomal dis-
orders occasionally, or even frequently, occur as
postzygotic events, resulting in two or more chromo-
somally different cell lines developed from a single zyg-
ote, the present approach is applicable also for
epigenetic studies of other constitutional mosaicisms,
with well-known examples including, apart from
CT8M, triplications of 8p, 9p, 12p, and 18p, trisomies
for chromosomes 9, 13, 14, 16, 18, 20, 21, and 22, and
Turner and Klinefelter syndromes [32].
By single cell cloning with subsequent gene expression
and methylation analyses, we here show that trisomy 8-
positive fibroblasts from a patient with CT8M display a
characteristic expression and methylation phenotypeFigure 3 Promoter-specific methylation and hydroxymethylation on t
respectively, compared with the male cultures. A rank plot of median-c
levels on the X chromosome reveals that the female reference culture gen
with (A) the average levels in the male cultures and (B) lower levels (P <0.that is clearly distinct from both disomy 8 cells and nor-
mal reference fibroblasts. In fact, PCA and HCA of glo-
bal as well as chr8-specific gene/miRNA expression and
methylation profiles grouped all the trisomy 8 cultures
in the same cluster branch, with no discernible effect by
long-term culturing [see Additional file 2: Figure S1].
When investigating which genes were the major ‘expres-
sion contributors to the observed clustering, we could,
not surprisingly, demonstrate that the majority of the
genes on chr8 in the trisomy 8 cultures were
overexpressed compared with the chr8 genes in the di-
somy 8/reference groups (Figure 1C and Additional file 3:
Figure S2 and Additional file 4: Figure S3). Hence, it
seems safe to assume that the clinical features as well
as the elevated risk for malignant myeloid disorders as-
sociated with CT8M [3,4] [see Additional file 1: Table
S1] is, at least partly, due to a direct chr8 gene dosage
effect. However, far from all deregulated genes and
non-coding RNAs in the trisomy 8-positive cells were
located on chr8 (Table 1), nor were all genes on this
chromosome up-regulated (Figure 1C). Thus, all genes
on chr8 are not dosage sensitive and trisomy 8 directly
or indirectly affects genes situated on other chromo-
somes as well. That not every gene on a constitutional
trisomic chromosome displays increased expression has
previously been clearly demonstrated in DS; in fact,
only a minority of the chr21 genes are overexpressed in
DS [25-28].
Pathway analysis of the deregulated genes in the tri-
somy 8 cells revealed that ‘cancer’ and ‘genetic disorder’
were the top two biological functions in the diseases and
disorders category and that ‘hematological system devel-
opment and function’ and ‘hematopoiesis’ were top
ranked in the physiological system development and
function category [see Additional file 5: Table S2]. The
latter may explain the increased incidence of myeloid
neoplasms in CT8M patients [4]. Furthermore, by usinghe X chromosome in the female culture is higher and lower,
entered promoter-specific methylation and hydroxymethylation log2
erally displays higher levels (P <0.05; t-test) of methylation compared
05; t-test) of hydroxymethylation compared with the male cultures.
Figure 4 (See legend on next page.)
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Figure 4 Accurate clustering of the trisomy 8, disomy 8, and reference cultures by PCA and supervised HCA of genome-wide
methylation patterns and significant hypomethylation of gene-poor regions on chromosome 8 only in the trisomy 8 cultures. (A) The
PCA identified 781 BACs that displayed significant differences between the trisomy 8, disomy 8, and reference cultures (left). Supervised HCA of
these BACs accurately clustered the subgroups, as illustrated in the heat map (right). (B) A similar pattern was observed when analyzing only chr8
data, with the PCA identifying 81 BACs (left) and HCA accurately clustering the subgroups (right). (C) Mean log2 ratio of the three culture
subgroups plotted against the number of genes on the BACs for chr8 revealed a significant hypomethylation of gene-poor regions in trisomy 8
cultures. The black curve shows the proportions that the BAC clones with different number of genes constitute of all BAC clones on chr 8; for
example, the BACs with no genes comprise 45% of all the BAC clones on this chromosome. (D) An independent and weighted ANOVA and a
Tukey HSD test verified the global hypomethylation of gene-poor regions on chr8 in trisomy 8 cultures but not in the disomy 8 or reference
cultures. (E) Mean log2 ratio of the three culture subgroups plotted against the number of genes on the BACs for chromosome 7 (used as an
example of another autosome) revealed no significant differences in genome-wide methylation. (F) Mean log2 ratio of female and male cultures
plotted against the number of genes on the BACs for chromosome X revealed significant hypomethylation of gene-poor regions only in the
female culture. ANOVA, analysis of variance; BAC, bacterial artificial chromosome; chr8, chromosome 8; HCA, hierarchial cluster analysis; HSD,
honestly significant difference; PCS, principal component analysis.
Davidsson et al. Epigenetics & Chromatin 2013, 6:18 Page 8 of 13
http://www.epigeneticsandchromatin.com/content/6/1/18a set of stringent inclusion criteria, several candidate
genes (Table 1) for some of the clinical manifestations
were identified [see Additional file 10: Table S4]. For ex-
ample, the presence of congenital heart disease could pos-
sibly be ascribed to the deregulation of the DES, LDB3,
POPDC2 and SLC4A3 genes [see Additional file 11:
Figure S7], all of which have previously been associated
with cardiac function and pathology, such as cardiomyop-
athy. In addition, eight of the candidate genes (CASP4,
COX6C, FNBP1, LRP12, RAB2A, RPS6KA1, TNFRSF10A
and TNKS; Table 1) have been associated with various
solid tumors. These genes also displayed a joint functional
association [see Additional file 11: Figure S7]. The
overexpression of MIR151, which was observed in the
trisomy 8 cultures only, is noteworthy because this
non-coding RNA has been suggested to play a role in
metastases [see Additional file 10: Table S4]. Furthermore,
the deregulation of AGPAT6, CPXM2, CRYAB, EDNRA,
ENTPD4, RAB2A and RAB3GAP2 as well as their func-
tional network [see Additional file 11: Figure S7] may
contribute to the mild to moderate mental retardation
seen in CT8M patients since these genes have all previ-
ously been associated with neurological development
and function. In addition, ELP3 and SNORD115-32, in-
volved in small nucleolar RNA processing and tran-
script elongation, were upregulated in the trisomy 8
cells. They could also play a role in the cognitive im-
pairment, considering that ELP3 regulates the matur-
ation of projection neurons and that SNORD115-32
has been implicated in splicing defects of the serotonin
receptor 2C in Prader-Willi syndrome [see Additional
file 10: Table S4].
The present analyses of global methylation and
hydroxymethylation patterns in trisomy 8-positive cells
may provide insights into the epigenetic consequences
of aneuploidy. As a proof-of-principle, we initially inves-
tigated methylation and hydroxymethylation of the X
chromosome in XX and XY cultures (Figure 3). As
expected, unlike its active counterpart, the inactivated Xchromosome (Xi) in the XX cells exhibited hypomethylation
of gene-poor regions but hypermethylation of a substan-
tial proportion of promoters (Figures 3A and 4F); the lat-
ter is considered a sex chromosome dosage compensation
mechanism [33-35]. Furthermore, and in agreement with
a previous study [36], we observed a general depletion of 5
hmC on the X chromosome compared with all autosomes
in both males and females [see Additional file 9:
Figure S6]. Interestingly, similar methylation and
hydroxymethylation profiles of chr8 were observed in the
trisomy 8 cells, which – compared with the disomic cells –
displayed depletion of 5 hmC (Figure 2) and a global
hypomethylation of gene-poor regions (Figure 4C). How-
ever, unlike the Xi, no elevated levels of promoter/CpG
island 5 mC content on chr8 were detected [see Additional
file 7: Figure S4]. It is interesting to note that the methyla-
tion status of chr8 observed in the present study is
reminiscent of the hypomethylation patterns of acquired
chromosomal gains reported in neoplasia, that is,
hypomethylation of gene-poor regions of the tri-/
tetrasomic chromosomes in high hyperdiploid child-
hood ALL and of trisomies 7 and 14 in colon cancer
[19,37]. Thus, we suggest that an association between
aneuploidy and globally lowered levels of 5 mC on the
gained chromosomes is valid for both constitutional and
acquired numerical changes. It should be emphasized,
however, that the hypomethylation seems to be confined
to genomic regions with no or few genes and this
phenomenon may, hence, be unrelated to gene expression
changes. Instead, it is possible that the hypomethylation of
gene-poor regions may be involved in chromatin
compartmentalization. In fact, it has been demonstrated
that absence of methylation influences chromatin
organization by increasing the nuclear clustering of peri-
centric heterochromatin [38]. It is hence feasible that the
hypomethylation of gene-poor regions results in altered
nuclear positioning of trisomic/tetrasomic chromosomes.
However, such an effect on the nuclear architecture
remains to be addressed experimentally.
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levels of the gene promoters/CpG islands on chr8 in the
trisomy 8 cells and on the X chromosome is currently un-
clear. In fact, it is debated whether the main cellular role of
5 hmC is to be a demethylation intermediate or if it consti-
tutes a bona fide epigenetic regulator, attracting chromatin
and transcriptional modifiers by itself. To date, no specific
5 hmC-binding protein has been found, arguing against
the latter mechanism [39]. Whether a demethylation inter-
mediate or not, it is clear that 5 hmC is situated primarily
in the gene-bodies of actively transcribed genes [40],
playing an important role in cellular lineage commitment
as well as in tissue-specific gene expression [41,42]. In sup-
port of this, it has recently been demonstrated [43] that the
most important predictor of 5 hmC content in a cell is the
tissue type from which it is derived and that the levels of
hydroxymethylation tend to decrease rapidly over time
when cells are cultured in vitro. This possible bias was
circumvented in our study by the use of identical cell
types as well as culture times. Interestingly, global loss
of 5 hmC has been associated with a variety of human
malignancies [44,45] with an inverse relationship be-
tween 5 hmC and cell proliferation [46]. Hence, the
hypohydroxymethylation on chr8 in the trisomy 8-
positive cells may contribute to the propensity for
myeloid malignancies in CT8M patients.Conclusions
In this study we used a mosaic genetic syndrome,
namely constitutional trisomy 8 mosaicism, to investi-
gate the epigenetic mechanisms associated with
aneuploidy using the patient’s own diploid cells as
control. This new approach circumvents the interpret-
ation difficulties introduced when comparing trisomic
cells with diploid cells from an unrelated control. We
profiled gene and miRNA expression as well as DNA
methylation and hydroxymethylation patterns. The
trisomic fibroblasts displayed a characteristic expres-
sion and methylation patterns, with the majority of
chromosome 8 genes in the trisomic cells being
overexpressed. However, not all deregulated genes
were located on this chromosome. Thus, trisomy 8
affects genes situated also on other chromosomes,
which in cooperation with the gene dosage effect might
influence the clinical features and elevated cancer
risk seen in this syndrome. Interestingly, trisomy 8-
positive cells also displayed a general depletion of
hydroxymethylation and a global hypomethylation of
gene-poor regions on chromosome 8, thus partly
mimicking the patterns seen in the inactivated X-
chromosome. This novel finding could be associated
with a general mechanism of chromatin processing of
additional chromosomes.Methods
Patient history and cytogenetic analyses
In 2002, a cytogenetic analysis of peripheral blood from
a 10-year-old boy with a history of developmental delay,
cryptorchidism and pectus excavatum revealed trisomy 8
in three of 25 analyzed metaphases. To confirm the
diagnosis of CT8M, a skin biopsy was analyzed in 2003,
revealing the karyotype 47,XY,+8[5]/46,XY[20].Single-cell cloning of fibroblasts from the patient
with CT8M
The primary culture for cytogenetic analysis of fibro-
blasts was established using standard methods in our
department, including initial mechanical disaggregation
and subsequent culture in RPM1 1640 (Invitrogen,
Carlsbad, CA, USA). After the chromosome analysis, the
fibroblasts were viably frozen in liquid nitrogen. For the
present study, the primary culture was thawed and cul-
tured in standard conditions with RPMI 1640 medium
(Invitrogen) containing 10% FBS (Sigma-Aldrich, St.
Louis, MO, USA) in a 50 ml (25 cm2) cell culture flask
(BD Falcon, Stockholm, Sweden). The culture was then,
at the time of subconfluence, passaged 1:3 by treatment
with 0.5% trypsin. One subculture was refrozen in liquid
nitrogen, one was analyzed by interphase fluorescence in
situ hybridization (FISH) using CEP-8 (Abbott Molecu-
lar, Des Plaines, IL, USA) to evaluate the proportions of
cells with either trisomy or disomy 8, and one was used
for further passages. After a short culture time of the lat-
ter, the cells were trypsinized, counted in a Bürker
chamber (Digital Bio, Seoul, Korea), and diluted so that
approximately one cell could be plated per well in 96-
well microtiter plates (BD Falcon). Viable confluent cell
cultures were used for further passages at a ratio of 1:1
to 24-well microtiter plates (BD Falcon). After reaching
confluence, all cell cultures were transferred 1:1 to 6-
well microtiter plates (BD Falcon). The cell cultures
were then resuspended, after which a fraction from each
was used for interphase FISH analysis with dual (Cy3
and Cy5) CEP-8 probes (Abbott Molecular). A minimum
of 285 (95%) of 300 normal or abnormal nuclei was used
as a cut-off to designate a culture as being either 46,XY
or 47,XY,+8. Three cultures with disomy 8 and three
with trisomy 8 were then passaged to 250 ml (75 cm2)
cell culture flasks (BD Falcon). Finally, these six cell
cultures were harvested simultaneously, and RNA and
DNA were extracted. The total time in culture was eight
weeks. Additional file 12: Figure S8 shows a schematic
overview of the culture process. The regional ethics
board at Lund University approved the study and
informed consent was obtained from the patient’s
guardians in accordance with the Declaration of
Helsinki.
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Primary dermal fibroblasts from a male neonate and a
female adult were obtained from the American Type
Culture Collection (Manassas, VA, USA). The cells were
maintained and passaged in RPMI 1640 medium
(Invitrogen) containing 10% FBS (Sigma-Aldrich) in
250 ml cell culture flasks (BD Falcon). The cultures were
cytogenetically characterized using conventional G-
banding analysis, revealing normal male and female
karyotypes, respectively.
Global gene and miRNA expression analysis
The mirVana kit (Invitrogen) was used to isolate RNA,
including miRNA, from the fibroblast cultures from the
CT8M patient and the references. The RNA concentra-
tion was measured with a NanoDrop 1000 spectropho-
tometer (Saveen & Werner AB, Malmö, Sweden), and
the quality of the RNA was assessed with a 2100
Bioanalyzer (Agilent Technologies, Santa Clara, CA,
USA). Total RNA was then hybridized to the Affymetrix
Human Gene 1.0 ST and the GeneChip miRNA arrays
(Affymetrix, Santa Clara, CA, USA) according to the
manufacturer’s protocols. Quality control and initial ana-
lyses were performed using the Expression Console and
the miRNA QC Tool (Affymetrix).
Bioinformatic analyses of gene and miRNA expression
HCA, PCA, multiclass significance analysis of microarrays
(SAM), and t-tests were used to compare expression pro-
files between fibroblasts with either disomy 8 (from the
CT8M patient and from the references) or trisomy 8 (from
the CT8M patient) and to identify differentially expressed
genes and miRNAs in the trisomic cells. Filtering, HCA,
and PCA of log2 transformed expression data were
performed using the Qlucore Omics Explorer v 2.0
(Qlucore, Lund, Sweden). For PCA, based on the Pearson
correlation matrix, the data were normalized by setting the
mean to 0 and σ to 1 and by filtering the variance on the
basis of σ/σmax. The Benjamini-Hochberg method was ap-
plied for error correction by q-value calculation. A P-value
of <0.05 was used as a cut-off. HCA of the genes identified
by PCA was performed on the basis of Euclidean metric
distance (samples) and Pearson correlation average linkage
test (genes).
Differentially expressed genes and miRNAs were iden-
tified using the correlation matrix-based PCA in com-
bination with SAM and t-tests (MultiExperiment Viewer
v 4.2) [20]. A multiple testing approach was applied,
with the criteria for inclusion being set to a P-value of
<0.05 for the t-tests and a q-value of ≤10% in the SAM
analysis, when comparing trisomy 8 with disomy 8
(CT8M only) and when comparing trisomy 8 with di-
somy 8 (CT8M and references grouped together). Only
genes and miRNAs significantly differentially expressedin all the above-mentioned statistical analyses were con-
sidered to be associated with CT8M. Functional associ-
ation networks of these genes were identified by the
GeneMANIA analysis (http://www.genemania.org/) [47].
qPCR validation
The qPCR analyses were performed using standard
protocols for predesigned TaqMan probes (Applied
Biosystems, Carlsbad, CA, USA) to validate over- or
underexpression of genes significantly associated with
the presence of trisomy 8 in the global gene expression
analyses (Table 1). The expression of transcripts of
the following seven genes was ascertained: AGPAT6
(Hs00410940_m1), CASP4 (Hs01031951_m1), CRYAB
(Hs00157107_m1), CPXM2 (Hs00406866_m1), EDNRA
(Hs03988672_m1), ENTPD4 (Hs01555223_m1), LRP12
(Hs00940649_m). Fold expression was calculated rela-
tive to endogenous control normalization of TBP
(Hs.590872_m1), encoding a TATA box binding pro-
tein. The rationale for using TBP as control was its
uniform expression in all cultures in the global gene
expression analyses. All qPCR analyses were performed
in triplicate and assayed on a 7500 real-time PCR
system (Applied Biosystems) and ΔΔCT values were
calculated using the comparative CT method [48].
MeDIP
From each sample (fibroblasts from the CT8M patient
and the references), 12 μg of DNA was diluted in stand-
ard Tris-ethylenediaminetetraacetic acid (TE) buffer to a
concentration of 75 ng/μl. The DNA was sonicated for
90 seconds with a Covaris S220 (Covaris, Woburn, MA,
USA) set to a 5% duty cycle, intensity value 3, and
200 cycles per burst to generate fragments ranging from
200 to 1,000 bp, as verified by gel electrophoresis. The
fragmented DNA was then diluted to a concentration of
13.4 ng/μl and denatured for 10 minutes at 95°C, after
which two input fractions (approximately 250 ng each),
serving as references in subsequent microarray hybrid-
izations (see below), were collected and stored at −80°C.
The remaining DNA aliquots were immunoprecipitated
overnight with monoclonal antibodies against either 5 mC
or 5 hmC using magnetic bead-based MeDIP and hMeDIP
kits (Diagenode, Liège, Belgium) to purify and isolate
the precipitated DNA. Both the input fraction and
the immunoprecipitated DNAs were then amplified
using a WGA2 kit (Sigma-Aldrich), generating sufficient
amounts (approximately 6 μg) for the various microarray
hybridizations detailed below.
Genome-wide methylation profiling
Of the methylated and input fraction DNAs, 1.5 μg was
differentially labeled with Cy3 and Cy5, respectively, and
hybridized to BAC array slides containing 32,433 tiling
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slides were produced at the SCIBLU DNA microarray
resource center at Lund University, Sweden. Labeling of
DNA, slide preparation, hybridization and analysis were
performed as described previously [49].
Classification as relative enrichment of methylation
was based on the log2 ratio for each of the BAC clones
smoothed with the factor of 0.33, with a positive ratio
indicating a higher degree of methylation. PCA and
HCA were performed as described above. The three
groups (disomy 8, trisomy 8, and references) were ana-
lyzed in relation to the gene density on each BAC clone
by ascertaining, using a custom-made script, the number
of annotated RefSeq genes on each consecutive clone.
All BACs on each chromosome were grouped in relation
to the number of genes they harbor, which most often
were 0 to 3 genes per BAC (total range 0 to 20). The
average log2 ratio for each group was then plotted
against their gene content. For every chromosome, each
gene count group, comprising at least 0.1% of the total
number of BAC clones on the chromosome, was ana-
lyzed using an independent and weighted ANOVA to
ascertain whether there were statistically significant dif-
ferences in 5mC levels between disomy 8, trisomy 8, and
references. The Tukey HSD test was applied to investi-
gate between which types of culture the significant dif-
ferences were present in. The analyses were performed
using the VassarStats website (http://vassarstats.net/).
Gene-specific methylation and hydroxymethylation
profiling
A total of 4 μg of the immunoprecipitated and input
fraction DNAs were analyzed using the Human DNA
Methylation 2.1 M Deluxe Promoter Arrays (Roche
NimbleGen, Madison, WI, USA) by the NimbleGen Ser-
vice Group, who performed the quality control, labeling,
hybridization, and scanning. This array platform covers
all 27,867 University of California Santa Cruz (UCSC)-
annotated CpG islands and promoter regions for all
known RefSeq genes as well as 730 annotated miRNA
promoters.
Signal intensity data were extracted from the scanned
images, with each feature on the array having a corre-
sponding log2 ratio, that is, the ratio of the input signals
for the precipitated and the input fraction DNAs. PCA
and HCA were performed as above. In addition, the log2
ratio was scaled in order to center the ratio data around
zero by subtracting the bi-weight mean for the log2 ratio
values for all features on the array from each log2 ratio
value. A modified algorithm for capturing microarray
enrichment (ACME) [50], where a fixed-length window
(750 bp) is placed around each consecutive probe, and
the one-sided Kolmogorov-Smirnov test were then ap-
plied on the scaled log2 ratio data to determine whetherthe probes were drawn from a significantly more positive
distribution (peak) of intensity log2 ratios than the other
probes in the array. The resulting score for each probe is
the -log10 P-value from the windowed Kolmogorov-
Smirnov test around that probe.
For every group (disomy 8, trisomy 8, and reference),
all genes with significant CpG island/promoter methyla-
tion scores were ascertained. Then, an edge-preserving
smoother analysis [51], using the Pott’s filter with the
penalty parameter set to 2 and the least allowed aberration
size limited to two clones, was performed to identify genes
that were highly enriched for 5 mC or 5 hmC in the three
different culture groups. The expression of each gene
was then investigated, after which possible associations
between hypermethylated and hyperhydroxymethylated
promoters/CpG islands and gene expression levels
were compared using a t-test. Underexpression and
overexpression were defined as fold changes ≤ −0.5
and ≥0.5, respectively; expression levels between these
cut-offs were considered ‘intermediate’.
All microarray data are minimum information about a
microarray experiment (MIAME) compliant and avail-
able to download at the Gene Expression Omnibus
Archive (http://www.ncbi.nlm.nih.gov/geo/) under the
accession number GSE40321.Additional files
Additional file 1: Table S1. Case reports on hematological disorders/
malignancies in patients with CT8M.
Additional file 2: Figure S1. Unsupervised HCA of gene and miRNA
expression reveals accurate clustering of the trisomy 8 subgroup. (A) HCA
of global gene expression in the disomy 8, trisomy 8, and reference
cultures clustered trisomy 8 in the same branch. (B) A similar pattern was
observed when co-analyzing gene and miRNA expression. (C) On the
other hand, HCA of only global miRNA expression did not cluster the
different subgroups accurately. (D) After long-term culturing of one
trisomy 8 culture (6lt) and one disomy 8 culture (1lt), HCA of global gene
and miRNA expression accurately grouped these together with their
short-term cultured counterparts.
Additional file 3: Figure S2. The majority of genes on chromosome 8
in the trisomy 8 cultures are upregulated compared with the disomy and
reference cultures. Median-centered expression of genes on chromosome
8 demonstrates that the majority of these genes in the trisomy 8 cultures
are upregulated compared with (A) the reference cultures as well as
compared with both the disomy 8 and (B) reference cultures.
Additional file 4: Figure S3. Validation of expression array results by
real-time quantitative PCR (qPCR). Seven genes were selected from
Table 1 and analyzed with qPCR using commercial Taq-Man probes. The
expression levels are presented as a fold change for each culture using
TBP as endogenous control. The qPCR analyses confirmed the over- or
underexpression of the seven genes in the trisomy 8-positive cultures
compared with the disomy 8 and reference cultures.
Additional file 5: Table S2. Ingenuity pathway analysis of 502
differentially expressed genes in the trisomy 8 and disomy 8 cultures.
Additional file 6: Table S3. Hypermethylated and
hyperhydroxymethylated promoters/CpG islands in relation to gene
expression.
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autosomes do not differ between the trisomy 8 and disomy 8/
refererence cultures. The levels of average promoter-specific methylation
on chromosomes (A) 2, (B) 6, (C) 7, and (D) 8 in the trisomy 8 cultures
and in the disomy 8 and reference cultures combined were log2-
converted, median-centered, and plotted against genomic positions. No
significant differences between the culture groups were observed.
Additional file 8: Figure S5. Promoter-specific hydroxymethylation
levels of chromosome 8, but not of the other autosomes, is significantly
lower in the trisomy 8 compared with the disomy 8/reference cultures.
The levels of average promoter-specific hydroxymethylation on
chromosomes (A) 2, (B) 6, (C) 7, and (D) 8 in the trisomy 8 cultures and in
the disomy 8 and references cultures combined cultures were log2-
converted, median-centered, and plotted against genomic positions.
Significantly lower levels (P < 0.05; t-test) were observed only for
chromosome 8 in the trisomy 8 cultures.
Additional file 9: Figure S6. The X chromosome is significantly less
hydroxymethylated compared with all autosomes. Measuring and
comparing the average intensity ratios of all autosomes combined with
the X chromosome, the promoters/CpG islands on the latter
chromosome were generally (irrespective of gender and culture group)
significantly (P <0.05; t-test) less hydroxymethylated.
Additional file 10: Table S4. Candidate genes for clinical manifestations.
Additional file 11: Figure S7. Functional association analyses of
cardiovascular dysfunction, cancer, and neurological development and
function reveal widespread interactions between the candidate genes.
Analyses of association data including protein and genetic interactions,
pathways, co-expression, co-localization, and protein domain similarity of
candidate genes derived from Table 1 reveal widespread interactions
between gene sets associated with (A) cardiovascular dysfunction, (B)
cancer, and (C) neurological development and function. Circles in grey
represent candidate genes (Table 1), whereas white circles represent
associated genes identified by the GeneMANIA analyses. Since the
analysis is three dimensional, the sizes of the circles vary in this two
dimensional representation. The colors of the lines connecting the
various genes denote the different types of functional associations, as
indicated by the color boxes.
Additional file 12: Figure S8. Schematic overview of single-cell
cloning of cells disomic and trisomic for chromosome 8, respectively.
From an original cell line from a patient with CT8M, with the karyotype
47,XY,+8[5]/46,XY[20], a total of three cultures with disomy 8 and three
cultures with trisomy 8 were generated. DNA and RNA from these
cultures were used for subsequent epigenetic analyses. In addition, two
commercially available control cell lines, with normal male and female
karyotypes, respectively, were included as references in all analyses.
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